– Managing multiple party process and bids
– Information audits and due diligences
– Multiple territories/jurisdictions

Call Us: +44 7880 787 626
Going the extra mile to guide patient-centric collaborations

– Managing multiple party process and bids
– Information audits and due diligences
– Multiple territories/jurisdictions

– NCEs, peptides, mAbs and mRNA
– Discovery to Approval; medtech; diagnostics
– Oncology/IO, Inflammation, Cardio/Metabolic, Neuroscience, Infectious Diseases

– Technology and product positioning
– Targeted companies’ insights
– Success metrics to agreed timeframes

– International network of contacts
– Non-dilutive partnering validation
– Hybrid model deployment

– Selective M&A
– Trade sales and exits
– Divestment of non-core assets/IP
